JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $273,000 | +145.9% | 40,853 | +282.9% | 0.00% | – |
| Q1 2021 | $111,000 | -89.8% | 10,669 | -92.9% | 0.00% | -100.0% |
| Q4 2020 | $1,086,000 | +7.6% | 150,731 | +38.2% | 0.00% | 0.0% |
| Q3 2020 | $1,009,000 | +34.0% | 109,061 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $753,000 | +50.9% | 118,074 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $499,000 | +2395.0% | 111,875 | +4901.1% | 0.00% | – |
| Q4 2019 | $20,000 | +300.0% | 2,237 | +56.1% | 0.00% | – |
| Q3 2019 | $5,000 | -44.4% | 1,433 | -24.5% | 0.00% | – |
| Q2 2019 | $9,000 | +125.0% | 1,898 | +222.2% | 0.00% | – |
| Q1 2019 | $4,000 | +300.0% | 589 | +181.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 209 | +2.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 205 | -1.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |